Business Seminar

 

Speaker: NAGASATO Toshiaki (President and Representative Director,  KM Biologics Co., Ltd. )

Title: Overview of KM Biologics Co., Ltd. and development of COVID-19 vaccine

 

Date&Time: 24 Dec. (Thu.) 2020,  15:00-16:30

Venue: Miyamoto Memorial Hall, Oe campus, Kumamoto University

*This seminar can also be attended through Zoom.

You can find the Zoom meeting ID and password  “HIGO企業・行政セミナー/ HIGO Business and Governmental Seminar（ZOOM）” on Moodle.

https://md.kumamoto-u.ac.jp/course/view.php?id=84771#section-10

*Simultaneous interpretation available only at the Miyamoto Memorial Hall.

 

Abstract:

The spread of COVID-19 that is yet to be controlled has become a social challenge in Japan and the world. Our company, KM Biologics Co., Ltd. has been involved in the development of vaccine to solve this challenge. As an alumnus of Kumamoto University, I will introduce an overview of our company and our approach to the COVID-19 infection. I hope this seminar will help the students who are interested in finding employment in a pharmaceutical company and are aiming for glocal activity to think about their future career.

 

■We will implement adequate measures to prevent the spread of new coronavirus infection■

・If you have a symptom related to cold (fever, cough, sore throat, etc.), please refrain from participating in the seminar.

・Please wear a mask.

・The maximum number of participants is limited to 50.

 

PDF: 201224bs

 

Email address for correspondance：

higo-program[atmark]jimu.kumamoto-u.ac.jp （[atmark]→@）